They were then able to give the mice higher doses of radiation therapy with no ill effect by blocking a mechanism by which endothelial cells communicate with each other.
He realized, five years before Harvard's Folkman would discover angiostatin, that blocking VEGF with a specially tailored drug might lead to a totally new type of cancer therapy.